Nanomix Corporation (NNMX)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.1490 - Volume
76 - Avg. Volume
0 - Market Cap (intraday)
4,900 - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3100 - Earnings Date Apr 5, 2024 - Apr 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urgent care centers, airports, schools, and others. The company is also developing a pipeline of other tests designed to enhance patient outcomes by making diagnostic information available. Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California.
nanomixdx.comRelated News
Performance Overview: NNMX
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NNMX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NNMX
Valuation Measures
Market Cap
4.90k
Enterprise Value
11.39M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.26
Price/Book (mrq)
--
Enterprise Value/Revenue
737.48
Enterprise Value/EBITDA
-1.49
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-558.67%
Return on Equity (ttm)
--
Revenue (ttm)
15.45k
Net Income Avi to Common (ttm)
-12.53M
Diluted EPS (ttm)
-0.3100
Balance Sheet and Cash Flow
Total Cash (mrq)
17.11k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.39M
Company Insights: NNMX
NNMX does not have Company Insights